Expression of c-Met in laryngeal carcinoma.

scientific article published in April 1998

Expression of c-Met in laryngeal carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S004280050174
P698PubMed publication ID9565342

P2093author name stringShin T
Tokunaga O
Sasatomi E
Mizokami H
Sawatsubashi M
P433issue4
P921main subjectlarynxQ9637
P304page(s)331-335
P577publication date1998-04-01
P1433published inVirchows ArchivQ19059548
P1476titleExpression of c-Met in laryngeal carcinoma.
P478volume432

Reverse relations

cites work (P2860)
Q49414583Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
Q58303525Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas
Q36518737Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma
Q38512195Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma
Q34133016Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas
Q33607965Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
Q49386899High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma
Q35746620Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma
Q77980218Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage
Q36375213Prognostic value of c-Met expression in oral squamous cell carcinoma
Q36446461Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma
Q38167258Role of met axis in head and neck cancer
Q37985518Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch
Q73586595Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Q50886906The Dual Inhibition of Met and EGFR by ME22S, a Novel Met/EGFR Bispecific Monoclonal Antibody, Suppresses the Proliferation and Invasion of Laryngeal Cancer.
Q47349579c-met overexpression in supraglottic laryngeal squamous cell carcinoma and its relation to lymph node metastases

Search more.